{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:04:53Z","timestamp":1792159493334,"version":"4.4.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Chronic insomnia is a substantial public health burden that often presents with co-occurring depression and anxiety. Randomized clinical trials and preliminary real-world evidence have shown that digitally delivered cognitive-behavioral therapy for insomnia (dCBT-I) is associated with improvements in insomnia, but real-world evidence is needed to determine the true impact of digital CBT-I. This pragmatic study aimed to evaluate the benefits of treating chronic insomnia with a tailored prescription digital therapeutic in a real-world population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective, single-arm clinical study involved adults aged 22-75 with chronic insomnia living in the US who had access to a mobile device. Participants accessed the FDA-cleared prescription digital therapeutic (PDT; Somryst\n                      <jats:sup>\u00ae<\/jats:sup>\n                      ) over a 9-week intervention period. The PDT delivers cognitive-behavioral therapy for insomnia via six interactive treatment cores and daily sleep diaries used for tailoring treatment. Participants completed validated patient-reported instruments at baseline, before completing treatment cores, immediately post-intervention, and at 6-month and 1-year follow-ups. The Insomnia Severity Index [ISI], the 8-item Patient Health Questionnaire [PHQ-8], and the Generalized Anxiety Disorder-7 scale [GAD-7] were used to determine the effect of the PDT on insomnia, depression, and anxiety.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After screening, 1565 adults accessed the PDT. 58% of those who began the program completed Core 4, established as exposure to all mechanisms of action in the digital therapeutic. For those who completed assessments for all 6 cores (48.4%), the ISI was lowered from 18.8 to a mean of 9.9 (P &amp;lt;.001). These scores continued to be lower than baseline at immediate post (11.0), 6-month (11.6), and 1-year follow-ups (12.2) (P &amp;lt;.001). The results of the PHQ-8 and GAD-7 also show significant decreases at all measured timepoints from baseline (P &amp;lt;.001). Of the patients that began the program, 908 (58.0%) were considered adherent and 733 (46.8%) completed all 6 cores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Data from the DREAM study contributes to the growing body of clinical evidence of how patients are utilizing a PDT in the real world, outside of controlled settings, offering insights for clinicians who use these therapeutics in practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>ClinicalTrials.gov<\/jats:uri>\n                      , identifier NCT04325464.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1450615","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:36:11Z","timestamp":1725928571000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of a prescription digital therapeutic for chronic insomnia on post-treatment insomnia severity, depression, and anxiety symptoms: results from the real-world DREAM study"],"prefix":"10.3389","volume":"15","author":[{"given":"Frances P.","family":"Thorndike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ojile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Edington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gerwien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson M.","family":"Wickwire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Ritterband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Riney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4863.201153","article-title":"Prevalence of chronic insomnia in adult patients and its correlation with medical comorbidities","volume":"5","author":"Bhaskar","year":"2016","journal-title":"J Family Med Prim Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2022.03.003","article-title":"Epidemiology of insomnia: prevalence, course, risk factors, and public health burden","volume":"17","author":"Morin","year":"2022","journal-title":"Sleep Med Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1186\/s12889-023-16329-9","article-title":"The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study","volume":"23","author":"Grandner","year":"2023","journal-title":"BMC Public Health"},{"key":"B4","article-title":"The societal and economic burden of insomnia in adults: An international study","author":"Hafner","year":"2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5665\/sleep\/32.1.55","article-title":"The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers","volume":"32","author":"Daley","year":"2009","journal-title":"Sleep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.11.1415","article-title":"Practice parameters for the psychological and behavioral treatment of insomnia: an update","volume":"29","year":"2006","journal-title":"Sleep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of sleep medicine clinical practice guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann Intern Med"},{"key":"B9","article-title":"Management of insomnia disorder in adults","volume":"98","author":"Salisbury-Afshar","year":"2018","journal-title":"Am Fam Physician"},{"key":"B10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5664\/jcsm.27286","article-title":"Clinical guideline for the evaluation and management of chronic insomnia in adults","volume":"4","author":"Schutte-Rodin","year":"2008","journal-title":"J Clin Sleep Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J sleep Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8986","article-title":"Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline","volume":"17","author":"Edinger","year":"2021","journal-title":"J Clin Sleep Med"},{"key":"B13","volume-title":"Insomnia: A clinical guide to assessment and treatment","author":"Morin","year":"2003"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2005.04.003","article-title":"Cognitive-behavioral therapy for primary insomnia","volume":"25","author":"Edinger","year":"2005","journal-title":"Clin Psychol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.20737","article-title":"Treatment of adult insomnia with cognitive-behavioral therapy","volume":"66","author":"Pigeon","year":"2010","journal-title":"J\u00a0Clin Psychol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/15402002.2016.1173551","article-title":"Where are the behavioral sleep medicine providers and where are they needed? a geographic assessment","volume":"14","author":"Thomas","year":"2016","journal-title":"Behav Sleep Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smrv.2015.10.004","article-title":"Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - a systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Zachariae","year":"2015","journal-title":"Sleep Med Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149139","article-title":"Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis","volume":"11","author":"Seyffert","year":"2016","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"101646","DOI":"10.1016\/j.smrv.2022.101646","article-title":"Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis","volume":"64","author":"Alimoradi","year":"2022","journal-title":"Sleep Med Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.smrv.2021.101567","article-title":"Comparative efficacy of digital cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis","volume":"61","author":"Hasan","year":"2022","journal-title":"Sleep Med Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1038\/s41598-023-28853-0","article-title":"Comparative efficacy of onsite, digital, and other settings for cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis","volume":"13","author":"Simon","year":"2023","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jamapsychiatry.2016.3249","article-title":"Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up: a randomized clinical trial","volume":"74","author":"Ritterband","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00536-2","article-title":"Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial","volume":"3","author":"Christensen","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2020.1852929","article-title":"Profile of somryst prescription digital therapeutic for chronic insomnia: overview of safety and efficacy","volume":"17","author":"Morin","year":"2020","journal-title":"Expert Rev Med Devices"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0004","article-title":"Protocol for Digital Real-world Evidence trial for Adults with insomnia treated via Mobile (DREAM): an open-label trial of a prescription digital therapeutic for treating patients with chronic insomnia","volume":"10","author":"Thorndike","year":"2021","journal-title":"J Comp Eff Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2011","journal-title":"Sleep Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Aff Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"A191","DOI":"10.1093\/sleep\/zsae067.0445","article-title":"Comparing adherence for a prescription digital therapeutic for insomnia across controlled and real-world settings","volume":"47","author":"Thorndike","year":"2024","journal-title":"Sleep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"141e150","DOI":"10.1080\/15402002.2010.487457","article-title":"Attrition and adherence in the online treatment of chronic insomnia","volume":"8","author":"Hebert","year":"2010","journal-title":"Behav Sleep Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brat.2015.07.008","article-title":"Predictors of dropout from internet-based self-help cognitive behavioral therapy for insomnia","volume":"73","author":"Yeung","year":"2015","journal-title":"Behav Res Ther"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1450615\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:36:14Z","timestamp":1725928574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1450615\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":32,"alternative-id":["10.3389\/fpsyt.2024.1450615"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1450615","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"article-number":"1450615"}}